All In Biotech

Drug Trial Radar · NCT06736041

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Last checked: Nov 19, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,714 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,714

Actual

Start

Dec 18, 2024

Primary completion

May 17, 2027

Study completion May 17, 2027

Sponsor

Lead sponsor
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
Dec 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 42 days, up to 89 days
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) compared with 20-valent pneumococcal vaccine (Prevnar 20, licensed pneumococcal conjugate vaccine) when they are administered with routine pediatric vaccines in infants aged from approximately 2 months (42 to 89 days). The study duration per participant will be up to approximately 19 months. The study vaccines (either PCV21 or 20-valent pneumococcal vaccines) will be administered at approximately 2, 4, 6 and 12 to 15 months of age. Routine pediatric vaccines will be given at the same timepoints. There will be 6 study visits: -Visit (V)01, V02 separated from V01 by 60 days, V03 separated from V02 by 60 days, V04 separated from V03 by 30 days, V05 at 12 months of age until 15 months of age, V06 separated from V05 by 30 days.

Conditions

  • Pneumococcal Immunization

Interventions

  • PCV21 vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • Prevnar 20 vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • M-M-R II vaccineBiological

    Pharmaceutical form:Powder, lyophilized, for suspension for reconstitution-Route of administration:Subcutaneous or Intramuscular

  • RotaTeqBiological

    Pharmaceutical form:Solution-Route of administration:Oral

  • Vaxelis vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • VarivaxBiological

    Pharmaceutical form:Powder, lyophilized, for suspension for reconstitution-Route of administration:Subcutaneous or Intramuscular

  • Hexaxim VaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seroresponse rate for PCV21 serotypesTime frame: 30 days post-dose 3
  2. IgG concentration for PCV21 serotypesTime frame: 30 days post-dose 3
  3. IgG concentration for PCV21 serotypesTime frame: 30 days post-dose 4

Locations

112 sites in 6 countries. Site status is shown where the registry gives one.

  • Sun City Clinical Research- Site Number : 8400247

    Glendale, Arizona

  • Eclipse Clinical Research- Site Number : 8400029

    Tucson, Arizona

  • Northwest Arkansas Pediatric Clinic- Site Number : 8400030

    Fayetteville, Arkansas

  • Southland Clinical Research Center- Site Number : 8400243

    Fountain Valley, California

  • Century Research Institute- Site Number : 8400065

    Huntington Park, California

  • Matrix Clinical Research - Huntington Park- Site Number : 8400012

    Huntington Park, California

  • Matrix Clinical Research - Los Angeles- Site Number : 8400013

    Los Angeles, California

  • University of California Los Angeles Medical Center- Site Number : 8400238

    Los Angeles, California

  • Pasadena Clinical Trials - Pasadena - North Madison Avenue- Site Number : 8400259

    Pasadena, California

  • FOMAT Medical Research - Pediatric, Infant & Adolescence Medicine- Site Number : 8400063

    Ventura, California

  • Velocity Clinical Research - Washington DC- Site Number : 8400049

    Washington D.C., District of Columbia

  • PAS Research- Site Number : 8400123

    Clearwater, Florida

  • Prohealth Research Center- Site Number : 8400159

    Doral, Florida

  • NurtureGen Research- Site Number : 8400205

    Homestead, Florida

  • EMDA Clinical Research- Site Number : 8400237

    Miami, Florida

  • Dade Research Center- Site Number : 8400007

    Miami, Florida

  • Acevedo Clinical Research Associates- Site Number : 8400089

    Miami, Florida

  • Miami Clinical Research Tower- Site Number : 8400189

    Miami, Florida

  • Vasconcello-Cohen MD Research, LLC- Site Number : 8400248

    Miami, Florida

  • Bio-Medical Research- Site Number : 8400147

    Miami, Florida

  • High Quality Research- Site Number : 8400245

    Miami, Florida

  • Riveldi Biomedical Research and Associates - Miami Lakes- Site Number : 8400032

    Miami Lakes, Florida

  • BioResearch Partner (BRP) - Premium Healthcare Medical Center - Miami Lakes- Site Number : 8400203

    Miami Lakes, Florida

  • Optimal Research Sites- Site Number : 8400232

    Orange City, Florida

  • SEC Clinical Research - Pensacola- Site Number : 8400003

    Pensacola, Florida

  • National Clinical Trials - Tampa- Site Number : 8400229

    Tampa, Florida

  • PAS Research - Tampa- Site Number : 8400002

    Tampa, Florida

  • Medical Research Partners - Ammon- Site Number : 8400239

    Ammon, Idaho

  • Bingham Memorial Hospital - Blackfoot- Site Number : 8400084

    Blackfoot, Idaho

  • Leavitt Women's Healthcare- Site Number : 8400085

    Idaho Falls, Idaho

  • Snake River Research- Site Number : 8400060

    Idaho Falls, Idaho

  • Clinical Research Prime Rexburg- Site Number : 8400250

    Rexburg, Idaho

  • Alliance for Multispeciality Research - El Dorado- Site Number : 8400010

    El Dorado, Kansas

  • Hutchinson Clinic- Site Number : 8400061

    Hutchinson, Kansas

  • Cotton O'Neil Pediatrics- Site Number : 8400009

    Topeka, Kansas

  • KUR Research at Columbia MD - 6220 Old Dobbin Lane- Site Number : 8400242

    Columbia, Maryland

  • Michigan Institute of Research- Site Number : 8400207

    Allen Park, Michigan

  • University of Missouri Hospital- Site Number : 8400244

    Columbia, Missouri

  • Vector Clinical Trials- Site Number : 8400249

    Las Vegas, Nevada

  • Hawthorne- Bienstar Lindenwold- Site Number : 8400256

    Lindenwold, New Jersey

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.